130 related articles for article (PubMed ID: 2990703)
21. Implications of the discovery of HTLV-III for the treatment of AIDS.
Yarchoan R; Mitsuya H; Matsushita S; Broder S
Cancer Res; 1985 Sep; 45(9 Suppl):4685s-4688s. PubMed ID: 2410113
[TBL] [Abstract][Full Text] [Related]
22. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
[TBL] [Abstract][Full Text] [Related]
23. Immune functions in homosexual men with antibodies to HTLV-III in Finland.
Krohn K; Ranki A; Antonen J; Valle SL; Suni J; Vaheri A; Saxinger C; Gallo RC
Clin Exp Immunol; 1985 Apr; 60(1):17-24. PubMed ID: 2988832
[TBL] [Abstract][Full Text] [Related]
24. Detection of antibodies to HTLV-I and -III in sera from Japanese hemophiliacs.
Abe T; Kinoshita T; Matsuda J; Ryu T; Ting RC; Aoki T; Robert-Guroff M; Miyakoshi H; Gallo RC
Cancer Res; 1985 Sep; 45(9 Suppl):4621s-4623s. PubMed ID: 2990696
[TBL] [Abstract][Full Text] [Related]
25. Adult T-cell leukemia/lymphoma in Jamaica and its relationship to human T-cell leukemia/lymphoma virus type I-associated lymphoproliferative disease.
Gibbs WN; Lofters WS; Campbell M; Hanchard B; LaGrenade L; Clark J; Cranston B; Saxinger C; Gallo R; Blattner WA
Princess Takamatsu Symp; 1984; 15():77-90. PubMed ID: 6100652
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany.
Erfle V; Hehlmann R; Mellert W; Krüger G; Seifried E; Heimpel H; Rasokat H; Lechler E; Holzer E; Hellstern P
Cancer Res; 1985 Sep; 45(9 Suppl):4627s-4629s. PubMed ID: 3860292
[TBL] [Abstract][Full Text] [Related]
27. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
[TBL] [Abstract][Full Text] [Related]
28. AIDS-related benign lymphadenopathy and malignant lymphoma: clinical aspects and virologic interactions.
Abrams DI; Kaplan LD; McGrath MS; Volberding PA
AIDS Res; 1986 Dec; 2 Suppl 1():S131-40. PubMed ID: 3828009
[TBL] [Abstract][Full Text] [Related]
29. Revision of the case definition of acquired immunodeficiency syndrome for national reporting--United States.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1985 Jun; 34(25):373-5. PubMed ID: 2989677
[TBL] [Abstract][Full Text] [Related]
30. [Properties and transmission of the AIDS virus].
Laufs R
Hautarzt; 1986 May; 37(5):245-9. PubMed ID: 3015839
[TBL] [Abstract][Full Text] [Related]
31. Spectrum of human T-cell lymphotropic virus type III infection in children. Recognition of symptomatic, asymptomatic, and seronegative patients.
Pahwa S; Kaplan M; Fikrig S; Pahwa R; Sarngadharan MG; Popovic M; Gallo RC
JAMA; 1986 May; 255(17):2299-305. PubMed ID: 3007791
[TBL] [Abstract][Full Text] [Related]
32. Antibody to human T-lymphotropic virus type III in wives of hemophiliacs. Evidence for heterosexual transmission.
Kreiss JK; Kitchen LW; Prince HE; Kasper CK; Essex M
Ann Intern Med; 1985 May; 102(5):623-6. PubMed ID: 2984972
[TBL] [Abstract][Full Text] [Related]
33. Epidemiological trends of AIDS in the United States.
Curran JW; Morgan WM; Starcher ET; Hardy AM; Jaffe HW
Cancer Res; 1985 Sep; 45(9 Suppl):4602s-4604s. PubMed ID: 2990692
[TBL] [Abstract][Full Text] [Related]
34. HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS.
Tenner-Racz K; Racz P; Bofill M; Schulz-Meyer A; Dietrich M; Kern P; Weber J; Pinching AJ; Veronese-Dimarzo F; Popovic M
Am J Pathol; 1986 Apr; 123(1):9-15. PubMed ID: 3008562
[TBL] [Abstract][Full Text] [Related]
35. [HTLV-III serology, epidemiology and clinical aspects of imprisoned i.v. drug-dependent males in Austria].
Pont J; Neuwald C; Kunz C; Werdenich W
Wien Klin Wochenschr; 1986 Jul; 98(14):454-7. PubMed ID: 3019019
[TBL] [Abstract][Full Text] [Related]
36. Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. Centers for Disease Control, Department of Health and Human Services.
Ann Intern Med; 1986 Oct; 105(4):558-9. PubMed ID: 3019202
[TBL] [Abstract][Full Text] [Related]
37. Human T-lymphotropic virus type III infection in previously immunocompromised hosts.
Groopman JE; Hammer SM; Sallan SE; Allan JD
J Clin Oncol; 1986 Apr; 4(4):540-3. PubMed ID: 3007685
[TBL] [Abstract][Full Text] [Related]
38. IgG antibodies to HTLV-III associated antigens in patients with AIDS and at risk for AIDS in The Netherlands.
Goudsmit J; Tersmette T; Kabel P; Miedema F; Melief C
AIDS Res; 1983-1984; 1(4):231-6. PubMed ID: 6100824
[TBL] [Abstract][Full Text] [Related]
39. Immunosuppression in homosexual men seronegative for HTLV-III.
Ranki A; Valle SL; Antonen J; Suni J; Jokipii L; Jokipii AM; Saxinger C; Krohn K
Cancer Res; 1985 Sep; 45(9 Suppl):4616s-4618s. PubMed ID: 3160458
[TBL] [Abstract][Full Text] [Related]
40. Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome.
Kaplan JE; Oleske JM; Getchell JP; Kalyanaraman VS; Minnefor AB; Zabala-Ablan M; Joshi V; Denny T; Cabradilla CD; Rogers MF
Pediatr Infect Dis; 1985; 4(5):468-71. PubMed ID: 2995933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
